- G71.12 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM G71.12 became effective on October 1, 2022.
- This is the American ICD-10-CM version of G71.12 – other international versions of ICD-10 G71.12 may differ.
ICD-10-CM G71.12 is grouped within Diagnostic Related Group(s):
- 091 Other disorders of nervous system with mcc
- 092 Other disorders of nervous system with cc
- 093 Other disorders of nervous system without cc/mcc
Applicable To
- Acetazolamide responsive myotonia congenita
- Dominant myotonia congenita [Thomsen disease]
- Myotonia levior
- Recessive myotonia congenita [Becker disease]
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to G71.12:
- myotonia congenita, recessive form > disease I42.3
- myotonia congenita > Becker I42.3
- Thomsen > Disease, diseased
- congenita (acetazolamide responsive) (dominant) (recessive) > Myotonia (acquisita) (intermittens) M62.89
- levior > Myotonia (acquisita) (intermittens) M62.89